Close Window

Digital Look Email A Friend

ImmuPharma's US partner receives FDA response on Lupuzor

Published by Josh White on 14th September 2022

(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced on Wednesday that its US partner for 'Lupuzor', Avion Pharmaceuticals, has received a written response from the Food and Drug Administration (FDA).

URL: http://www.digitallook.com/dl/news/story/32962318/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.